Lidocaine Intravenous Infusion
Lidocaine Intravenous Infusion is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Application of Low-dose Muscle Relaxants in Bronchoscopic Interventional Procedures
Safety and Efficacy of Lidocaine Versus Ketamine Infusion for Resistant Orofacial Pain
Ketamine and Lidocaine Infusion in Refractory Chronic Migraine
Impact of Intraoperative Non-invasive Analgesia Monitoring Using Nociception Level Index on Patient Management
Effect of Addition of Dexmedetomidine or Ketamine to Intravenous Infusion of Lidocaine on Proinflammatory Cytokines in Pelvi-abdominal Cancer Surgeries.
Clinical Trials (6)
Application of Low-dose Muscle Relaxants in Bronchoscopic Interventional Procedures
Safety and Efficacy of Lidocaine Versus Ketamine Infusion for Resistant Orofacial Pain
Ketamine and Lidocaine Infusion in Refractory Chronic Migraine
Impact of Intraoperative Non-invasive Analgesia Monitoring Using Nociception Level Index on Patient Management
Effect of Addition of Dexmedetomidine or Ketamine to Intravenous Infusion of Lidocaine on Proinflammatory Cytokines in Pelvi-abdominal Cancer Surgeries.
Intraoperative Lidocaine Infusion for Analgesia (ILIA)
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6